Encompass Health revenue and financials

EHC · NYSE · USD

$122.63−1.65%−$2.06

Close · October 7, 2026

In the fiscal year ended December 2025, Encompass Health reported revenue of $5.94B (+10.46% year over year). Net income was $566.2M, a net margin of 9.5%.

Annual revenue · 2025: $5.94B
  1. $4.01B2021
  2. $4.35B2022
  3. $4.8B2023
  4. $5.37B2024
  5. $5.94B2025

Fiscal year ending in December. Sources and method on the page Methodology and sources.

At a glance

Revenue growth
+10.46%
2025 vs 2024
Net income growth
+24.25%
2025 vs 2024
Net margin
9.5%
2024: 8.5%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

ItemQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Total revenue1,5971,5871,5451,4781,4581,4551,4051,3511,3011,3161,2471,207
Cost of revenue886882866849831825819793758770735713
Gross profit711704679628627631586558543546512494
Selling, general and administrative77.373.488.271.074.167.275.068.464.764.267.164.0
Operating income288302283244259267232209216218190179
EBIT288302283244259267232209216218190179
EBITDA379389370326339346310288289288260247
Interest expense32.831.830.230.830.431.833.034.934.335.234.935.9
Pre-tax income262289258220237239201184186178165145
Income tax53.656.455.444.951.041.637.636.038.338.337.230.3
Net income15419514612714215212110811411387.685.3
Net income to common shareholders15419414612614215112010811311287.084.7
Basic EPS1.551.961.451.261.411.501.201.081.131.120.870.85
Diluted EPS1.541.931.431.241.391.481.181.061.121.100.860.84
Average shares (basic)98.899.210010110110110099.999.999.899.599.5
Average shares (diluted)100101102102102102102102102102102101
Dividend per share0.190.190.190.190.170.170.170.170.150.150.150.15